Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
CC | GO:0005774 | vacuolar membrane | 79/2686 | 412/19717 | 0.0009315 | 0.01318 | 0.01029 | 79 | RABC91 | |
CC | GO:0030670 | phagocytic vesicle membrane | 21/2686 | 76/19717 | 0.0009611 | 0.01335 | 0.01042 | 21 | RABC91 | |
MF | GO:0042277 | peptide binding | 77/2598 | 295/17697 | 0.000000178 | 0.0001508 | 0.000135 | 77 | RABC91 | |
MF | GO:0033218 | amide binding | 88/2598 | 356/17697 | 0.000000337 | 0.0001508 | 0.000135 | 88 | RABC91 | |
MF | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process | 20/2598 | 42/17697 | 0.000000394 | 0.0001508 | 0.000135 | 20 | RABC91 | |
MF | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process | 14/2598 | 25/17697 | 0.00000187 | 0.000538 | 0.0004816 | 14 | RABC91 | |
MF | GO:1901681 | sulfur compound binding | 61/2598 | 250/17697 | 0.0000309 | 0.007104 | 0.006358 | 61 | RABC91 | |
MF | GO:0035257 | nuclear hormone receptor binding | 41/2598 | 152/17697 | 0.0000563 | 0.01078 | 0.009645 | 41 | RABC91 | |
MF | GO:0019207 | kinase regulator activity | 51/2598 | 207/17697 | 0.0001022 | 0.01678 | 0.01502 | 51 | RABC91 | |
MF | GO:0005048 | signal sequence binding | 17/2598 | 46/17697 | 0.0001601 | 0.01755 | 0.01571 | 17 | RABC91 | |
MF | GO:0050662 | coenzyme binding | 66/2598 | 291/17697 | 0.0001604 | 0.01755 | 0.01571 | 66 | RABC91 | |
MF | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances | 32/2598 | 115/17697 | 0.0001894 | 0.01755 | 0.01571 | 32 | RABC91 | |
MF | GO:0043492 | ATPase activity, coupled to movement of substances | 32/2598 | 115/17697 | 0.0001894 | 0.01755 | 0.01571 | 32 | RABC91 | |
MF | GO:0042605 | peptide antigen binding | 13/2598 | 31/17697 | 0.0002184 | 0.01755 | 0.01571 | 13 | RABC91 | |
MF | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 20/2598 | 60/17697 | 0.0002257 | 0.01755 | 0.01571 | 20 | RABC91 | |
MF | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 16/2598 | 43/17697 | 0.0002263 | 0.01755 | 0.01571 | 16 | RABC91 | |
MF | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 14/2598 | 35/17697 | 0.0002292 | 0.01755 | 0.01571 | 14 | RABC91 | |
MF | GO:0019887 | protein kinase regulator activity | 44/2598 | 180/17697 | 0.0003545 | 0.02546 | 0.02278 | 44 | RABC91 | |
MF | GO:0005539 | glycosaminoglycan binding | 53/2598 | 229/17697 | 0.0004052 | 0.02736 | 0.02449 | 53 | RABC91 | |
MF | GO:0061134 | peptidase regulator activity | 51/2598 | 219/17697 | 0.0004422 | 0.02736 | 0.02449 | 51 | RABC91 | |
MF | GO:0004896 | cytokine receptor activity | 27/2598 | 96/17697 | 0.0004831 | 0.02736 | 0.02449 | 27 | RABC91 | |
MF | GO:0003954 | NADH dehydrogenase activity | 16/2598 | 46/17697 | 0.0005477 | 0.02736 | 0.02449 | 16 | RABC91 | |
MF | GO:0008137 | NADH dehydrogenase (ubiquinone) activity | 16/2598 | 46/17697 | 0.0005477 | 0.02736 | 0.02449 | 16 | RABC91 | |
MF | GO:0032813 | tumor necrosis factor receptor superfamily binding | 16/2598 | 46/17697 | 0.0005477 | 0.02736 | 0.02449 | 16 | RABC91 | |
MF | GO:0050136 | NADH dehydrogenase (quinone) activity | 16/2598 | 46/17697 | 0.0005477 | 0.02736 | 0.02449 | 16 | RABC91 | |
MF | GO:0008201 | heparin binding | 41/2598 | 169/17697 | 0.0006504 | 0.03039 | 0.0272 | 41 | RABC91 | |
MF | GO:0051427 | hormone receptor binding | 44/2598 | 185/17697 | 0.0006612 | 0.03039 | 0.0272 | 44 | RABC91 | |
MF | GO:0015405 | P-P-bond-hydrolysis-driven transmembrane transporter activity | 32/2598 | 123/17697 | 0.0006961 | 0.03076 | 0.02754 | 32 | RABC91 | |
MF | GO:0005543 | phospholipid binding | 87/2598 | 427/17697 | 0.0007725 | 0.03288 | 0.02943 | 87 | RABC91 | |
MF | GO:0015399 | primary active transmembrane transporter activity | 32/2598 | 125/17697 | 0.0009364 | 0.03842 | 0.03439 | 32 | RABC91 |